keyword
https://read.qxmd.com/read/37520563/antibody-dependent-cellular-cytotoxicity-inducing-antibodies-enhance-the-natural-killer-cell-anti-cancer-response-against-patient-derived-pancreatic-cancer-organoids
#41
JOURNAL ARTICLE
Nicky A Beelen, Merel R Aberle, Virginia Bruno, Steven W M Olde Damink, Gerard M J Bos, Sander S Rensen, Lotte Wieten
INTRODUCTION: Pancreatic cancer is associated with poor prognosis, and limited treatment options are available for the majority of patients. Natural killer (NK) cells in combination with antibodies inducing antibody-dependent cell-mediated cytotoxicity (ADCC) could be a highly effective new therapeutic option in pancreatic cancer. Accurate predictive preclinical models are needed to develop successful NK cell immunotherapy. Tumor organoids, in vitro 3D organ-like structures that retain important pathophysiological characteristics of the in vivo tumor, may provide such a model...
2023: Frontiers in Immunology
https://read.qxmd.com/read/37455016/expression-of-mir-425-5p-in-pancreatic-carcinoma-and-its-correlation-with-tumor-immune-microenvironment
#42
JOURNAL ARTICLE
Shuo Jian, Dehua Kong, Jieli Tian
Background: Pancreatic carcinoma (PC) is a global health threat with a high death rate. miRNAs are implicated in tumor initiation and progression. This study explored the expression of miR-425-5p in PC patients and its correlation with tumor immune microenvironment (TIME). Method: miR-425-5p expression in cancer tissues and adjacent non-tumor tissues of PC patients was examined by RT-qPCR. The levels of immune cells and cytokines were measured by flow cytometry and ELISA. The correlation of miR-425-5p with TNM stage and TIME was assessed by Spearman method...
December 2023: Journal of Investigative Surgery: the Official Journal of the Academy of Surgical Research
https://read.qxmd.com/read/37443348/combination-of-pembrolizumab-and-pelareorep-promotes-anti-tumour-immunity-in-advanced-pancreatic-adenocarcinoma-pdac
#43
JOURNAL ARTICLE
Devalingam Mahalingam, Siqi Chen, Ping Xie, Houra Loghmani, Thomas Heineman, Aparna Kalyan, Sheetal Kircher, Irene B Helenowski, Xinlei Mi, Victoria Maurer, Matt Coffey, Mary Mulcahy, Al- Benson, Bin Zhang
BACKGROUND: We previously reported activity of pelareorep, pembrolizumab and chemotherapy. Patients developed new T-cell clones and increased peripheral T-cell clonality, leading to an inflamed tumour. To evaluate a chemotherapy-free regimen, this study assesses if pelareorep and pembrolizumab has efficacy by inducing anti-tumour immunological changes (NCT03723915). METHODS: PDAC patients who progressed after first-line therapy, received iv pelareorep induction with pembrolizumab every 21-days...
July 13, 2023: British Journal of Cancer
https://read.qxmd.com/read/37395796/transformation-of-immunosuppressive-mtkras-tumors-into-immunostimulatory-tumors-by-nerofe-and-doxorubicin
#44
JOURNAL ARTICLE
Joel Ohana, Uziel Sandler, Orly Devary, Yoram Devary
Members of the rat sarcoma viral oncogene (RAS) subfamily KRAS are frequently mutated oncogenes in human cancers and have been identified in pancreatic ductal, colorectal, and lung adenocarcinomas. In this study, we show that a derivative of the hormone peptide Tumor Cell Apoptosis Factor (TCApF), Nerofe™ (dTCApFs), in combination with Doxorubicin (DOX) substantially reduces viability of tumor cells. It was observed that the combination of Nerofe and DOX downregulated KRAS signaling via miR217 upregulation, resulting in enhanced apoptosis of tumor cells...
July 1, 2023: Oncotarget
https://read.qxmd.com/read/37377605/safety-and-clinical-response-to-combined-immunotherapy-with-autologous-inkt-cells-and-pd-1-cd8-t-cells-in-patients-failing-first-line-chemotherapy-in-stage-iv-pancreatic-cancer
#45
JOURNAL ARTICLE
Jing Wang, Xiaobo Cheng, Yanling Jin, Bili Xia, Ran Qin, Wei Zhang, Huiliang Hu, Xiaoting Mao, Liting Zhou, Jia Yan, Xiaoyan Zhang, Jianqing Xu
PURPOSE: A phase I clinical trial was conducted to assess the safety and feasibility of invariant natural killer T (iNKT) cells combined with PD-1+ CD8+ T cells in patients with advanced pancreatic cancer and failing the first-line chemotherapy. PATIENTS AND METHODS: Fifteen eligible patients were enrolled, of whom 9 received at least three cycles of treatment each. In total, 59 courses were administered. RESULTS: Fever was the most common adverse event, peaking at about 2-4 hours after cell infusion and reverting within 24 hours without treatment in all patients...
June 2023: Cancer Res Commun
https://read.qxmd.com/read/37304055/microrna-analysis-of-natural-killer-cell-derived-exosomes-the-microrna-let-7b-5p-is-enriched-in-exosomes-and-participates-in-their-anti-tumor-effects-against-pancreatic-cancer-cells
#46
JOURNAL ARTICLE
Anna Laura Di Pace, Andrea Pelosi, Piera Filomena Fiore, Nicola Tumino, Francesca Besi, Linda Quatrini, Silvia Santopolo, Paola Vacca, Lorenzo Moretta
Natural Killer (NK) cells are important components of the immune system in the defense against tumor growth and metastasis. They release exosomes containing proteins and nucleic acids, including microRNAs (miRNAs). NK-derived exosomes play a role in the anti-tumor NK cell function since they are able to recognize and kill cancer cells. However, the involvement of exosomal miRNAs in the function of NK exosomes is poorly understood. In this study, we explored the miRNA content of NK exosomes by microarray as compared to their cellular counterparts...
2023: Oncoimmunology
https://read.qxmd.com/read/37197660/sequential-therapy-with-supercharged-nk-cells-with-either-chemotherapy-drug-cisplatin-or-anti-pd-1-antibody-decreases-the-tumor-size-and-significantly-enhances-the-nk-function-in-hu-blt-mice
#47
JOURNAL ARTICLE
Kawaljit Kaur, Po-Chun Chen, Meng-Wei Ko, Ao Mei, Emanuela Senjor, Subramaniam Malarkannan, Janko Kos, Anahid Jewett
INTRODUCTION AND METHODS: In this study we report that sequential treatment of supercharged NK (sNK) cells with either chemotherapeutic drugs or check-point inhibitors eliminate both poorly differentiated and well differentiated tumors in-vivo in humanized-BLT mice. BACKGROUND AND RESULTS: sNK cells were found to be a unique population of activated NK cells with genetic, proteomic, and functional attributes that are very different from primary untreated or IL-2 treated NK cells...
2023: Frontiers in Immunology
https://read.qxmd.com/read/37169953/combinatorial-immunotherapy-with-gemcitabine-and-ex-vivo-expanded-nk-cells-induces-anti-tumor-effects-in-pancreatic-cancer
#48
JOURNAL ARTICLE
Eun-Kyoung Koh, Hong-Rae Lee, Woo-Chang Son, Ga-Young Park, Juhee Kim, Jae-Ho Bae, You-Soo Park
Pancreatic cancer is difficult to diagnose at the initial stage and is often discovered after metastasis to nearby organs. Gemcitabine is currently used as a standard treatment for pancreatic cancer. However, since chemotherapy for pancreatic cancer has not yet reached satisfactory therapeutic results, adjuvant chemotherapy methods are attempted. It can be expected that combining immune cell therapy with existing anticancer drug combination treatment will prevent cancer recurrence and increase survival rates...
May 11, 2023: Scientific Reports
https://read.qxmd.com/read/37142692/ezh2-inhibition-remodels-the-inflammatory-senescence-associated-secretory-phenotype-to-potentiate-pancreatic-cancer-immune-surveillance
#49
JOURNAL ARTICLE
Loretah Chibaya, Katherine C Murphy, Kelly D DeMarco, Sneha Gopalan, Haibo Liu, Chaitanya N Parikh, Yvette Lopez-Diaz, Melissa Faulkner, Junhui Li, John P Morris, Yu-Jui Ho, Sachliv K Chana, Janelle Simon, Wei Luan, Amanda Kulick, Elisa de Stanchina, Karl Simin, Lihua Julie Zhu, Thomas G Fazzio, Scott W Lowe, Marcus Ruscetti
Immunotherapies that produce durable responses in some malignancies have failed in pancreatic ductal adenocarcinoma (PDAC) due to rampant immune suppression and poor tumor immunogenicity. We and others have demonstrated that induction of the senescence-associated secretory phenotype (SASP) can be an effective approach to activate anti-tumor natural killer (NK) cell and T cell immunity. In the present study, we found that the pancreas tumor microenvironment suppresses NK cell and T cell surveillance after therapy-induced senescence through enhancer of zeste homolog 2 (EZH2)-mediated epigenetic repression of proinflammatory SASP genes...
June 2023: Nature Cancer
https://read.qxmd.com/read/37116489/simultaneous-targeting-of-pd-1-and-il-2r%C3%AE-%C3%AE-with-radiation-therapy-inhibits-pancreatic-cancer-growth-and-metastasis
#50
JOURNAL ARTICLE
Miles Piper, Maureen Hoen, Laurel B Darragh, Michael W Knitz, Diemmy Nguyen, Jacob Gadwa, Greta Durini, Idil Karakoc, Abby Grier, Brooke Neupert, Benjamin Van Court, Khalid N M Abdelazeem, Justin Yu, Nicholas A Olimpo, Sophia Corbo, Richard Blake Ross, Tiffany T Pham, Molishree Joshi, Ross M Kedl, Anthony J Saviola, Maria Amann, Pablo Umaña, Laura Codarri Deak, Christian Klein, Angelo D'Alessandro, Sana D Karam
In pancreatic ductal adenocarcinoma (PDAC) patients, we show that response to radiation therapy (RT) is characterized by increased IL-2Rβ and IL-2Rγ along with decreased IL-2Rα expression. The bispecific PD1-IL2v is a PD-1-targeted IL-2 variant (IL-2v) immunocytokine with engineered IL-2 cis targeted to PD-1 and abolished IL-2Rα binding, which enhances tumor-antigen-specific T cell activation while reducing regulatory T cell (Treg) suppression. Using PD1-IL2v in orthotopic PDAC KPC-driven tumor models, we show marked improvement in local and metastatic survival, along with a profound increase in tumor-infiltrating CD8+ T cell subsets with a transcriptionally and metabolically active phenotype and preferential activation of antigen-specific CD8+ T cells...
May 8, 2023: Cancer Cell
https://read.qxmd.com/read/37109675/comprehensive-investigation-illustrates-the-role-of-m2-macrophages-and-its-related-genes-in-pancreatic-cancer
#51
JOURNAL ARTICLE
Danying Zhang, Wenqing Tang, Xizhong Shen, Shuqiang Weng, Ling Dong
Background and Objectives: M2 macrophages play an important role in cancers. Our study aimed to illustrate the effect of M2 macrophages in pancreatic cancer (PC). Materials and Methods: The open-access data used for analysis were downloaded from The Cancer Genome Atlas Program database, as well as some online databases. R software was mainly used for data analysis based on the specific packages. Results: Here, we comprehensively investigated the role of M2 macrophages and their related genes in PC. We performed the biological enrichment of M2 macrophages in PC...
April 6, 2023: Medicina
https://read.qxmd.com/read/37090547/disruption-of-desmoplastic-stroma-overcomes-restrictions-to-t-cell-extravasation-immune-exclusion-and-immunosuppression-in-solid-tumors
#52
Zebin Xiao, Zhen Lu, Leslie Todd, Li Huang, Meghan Kopp, Lili Huang, Wenqun Zhong, Yue Li, Wei Guo, John Scholler, Carl H June, Steven M Albelda, Ellen Pur
The desmoplastic stroma in solid tumors presents a formidable challenge to immunotherapies that rely on endogenous or adoptively transferred T cells, however, the mechanisms are poorly understood. To define mechanisms involved, we treated established desmoplastic pancreatic tumors with CAR T cells directed to fibroblast activation protein (FAP), an enzyme highly overexpressed on a subset of cancer-associated fibroblasts (CAFs). Depletion of FAP + CAFs resulted in loss of the structural integrity of desmoplastic matrix...
April 16, 2023: bioRxiv
https://read.qxmd.com/read/37035749/a-novel-natural-killer-cell-related-signatures-to-predict-prognosis-and-chemotherapy-response-of-pancreatic-cancer-patients
#53
JOURNAL ARTICLE
Yongting Lan, Qing Jia, Min Feng, Peiqing Zhao, Min Zhu
Background: Natural killer (NK) cells are involved in monitoring and eliminating cancers. The purpose of this study was to develop a NK cell-related genes (NKGs) in pancreatic cancer (PC) and establish a novel prognostic signature for PC patients. Methods: Omic data were downloaded from The Cancer Genome Atlas Program (TCGA), Gene Expression Omnibus (GEO), International Cancer Genome Consortium (ICGC), and used to generate NKG-based molecular subtypes and construct a prognostic signature of PC. NKGs were downloaded from the ImmPort database...
2023: Frontiers in Genetics
https://read.qxmd.com/read/37034762/multi-omic-characterization-reveals-a-distinct-molecular-landscape-in-young-onset-pancreatic-cancer
#54
Ifeanyichukwu Ogobuiro, Yasmine Baca, Jennifer R Ribeiro, Phillip Walker, Gregory C Wilson, Prateek Gulhati, John L Marshall, Rachna T Shroff, David Spetzler, Matthew J Oberley, Daniel E Abbott, Hong Jin Kim, David A Kooby, Shishir K Maithel, Syed A Ahmad, Nipun B Merchant, Joanne Xiu, Peter J Hosein, Jashodeep Datta
PURPOSE: Using a real-world database with matched genomic-transcriptomic molecular data, we sought to characterize the distinct molecular correlates underlying clinical differences between young-onset pancreatic cancer (YOPC; <50-yrs.) and average-onset pancreatic cancer (AOPC; ≥70-yrs.) patients. METHODS: We analyzed matched whole-transcriptome and DNA sequencing data from 2430 patient samples (YOPC, n=292; AOPC, n=2138) from the Caris Life Sciences database (Phoenix, AZ)...
March 29, 2023: medRxiv
https://read.qxmd.com/read/36993337/perturbomics-of-tumor-infiltrating-nk-cells
#55
Lei Peng, Paul A Renauer, Lupeng Ye, Luojia Yang, Jonathan J Park, Ryan D Chow, Yueqi Zhang, Qianqian Lin, Meizhu Bai, Angelica Sanchez, Yongzhan Zhang, Stanley Z Lam, Sidi Chen
Natural killer (NK) cells are an innate immune cell type that serves at the first level of defense against pathogens and cancer. NK cells have clinical potential, however, multiple current limitations exist that naturally hinder the successful implementation of NK cell therapy against cancer, including their effector function, persistence, and tumor infiltration. To unbiasedly reveal the functional genetic landscape underlying critical NK cell characteristics against cancer, we perform perturbomics mapping of tumor infiltrating NK cells by joint in vivo AAV-CRISPR screens and single cell sequencing...
March 15, 2023: bioRxiv
https://read.qxmd.com/read/36991390/first-in-human-phase-1-clinical-trial-of-anti-core-1-o-glycans-targeting-monoclonal-antibody-neo-201-in-treatment-refractory-solid-tumors
#56
JOURNAL ARTICLE
Christopher B Cole, Maria Pia Morelli, Massimo Fantini, Markku Miettinen, Patricia Fetsch, Cody Peer, William D Figg, Tyler Yin, Nicole Houston, Ann McCoy, Stanley Lipkowitz, Alexandra Zimmer, Jung-Min Lee, Miroslava Pavelova, Erin N Villanueva, Kathryn Trewhitt, B Brooke Solarz, Maria Fergusson, Sharon A Mavroukakis, Anjum Zaki, Kwong Y Tsang, Philip M Arlen, Christina M Annunziata
BACKGROUND: NEO201 is a humanized IgG1 monoclonal antibody (mAb) generated against tumor-associated antigens from patients with colorectal cancer. NEO-201 binds to core 1 or extended core 1 O-glycans expressed by its target cells. Here, we present outcomes from a phase I trial of NEO-201 in patients with advanced solid tumors that have not responded to standard treatments. METHODS: This was a single site, open label 3 + 3 dose escalation clinical trial...
March 29, 2023: Journal of Experimental & Clinical Cancer Research: CR
https://read.qxmd.com/read/36990268/scrna-seq-and-imaging-mass-cytometry-analyses-unveil-inkt-cells-mediated-anti-tumor-immunity-in-pancreatic-cancer-liver-metastasis
#57
JOURNAL ARTICLE
Qijun Yi, Jie Wang, Tingting Liu, Yi Yao, Ian Loveless, Kalpana Subedi, Jugmohit Toor, Indra Adrianto, Hua Xiao, Bin Chen, Howard C Crawford, Deyu Fang, Li Zhou, Qing-Sheng Mi
Invariant natural killer T (iNKT) cells are innate-like T cells that are abundant in liver sinusoids and play a critical role in tumor immunity. However, the role of iNKT cells in pancreatic cancer liver metastasis (PCLM) has not been fully explored. In this study, we employed a hemi-spleen pancreatic tumor cell injection mouse model of PCLM, a model that closely mimics clinical conditions in humans, to explore the role of iNKT cells in PCLM. Activation of iNKT cells with α-galactosylceramide (αGC) markedly increased immune cell infiltration and suppressed PCLM progression...
March 27, 2023: Cancer Letters
https://read.qxmd.com/read/36980580/peptidergic-systems-and-cancer-focus-on-tachykinin-and-calcitonin-calcitonin-gene-related-peptide-families
#58
REVIEW
Manuel Lisardo Sánchez, Francisco D Rodríguez, Rafael Coveñas
The roles played by the peptides belonging to the tachykinin (neurokinin A and B) and calcitonin/calcitonin gene-related peptide (adrenomedullin, adrenomedullin 2, amylin, and calcitonin gene-related peptide (CGRP)) peptide families in cancer development are reviewed. The structure and dynamics of the neurokinin (NK)-2, NK-3, and CGRP receptors are studied together with the intracellular signaling pathways in which they are involved. These peptides play an important role in many cancers, such as breast cancer, colorectal cancer, glioma, lung cancer, neuroblastoma, oral squamous cell carcinoma, phaeochromocytoma, leukemia, bladder cancer, endometrial cancer, Ewing sarcoma, gastric cancer, liver cancer, melanoma, osteosarcoma, ovarian cancer, pancreatic cancer, prostate cancer, renal carcinoma, and thyroid cancer...
March 9, 2023: Cancers
https://read.qxmd.com/read/36937004/the-six1-ldha-axis-promotes-lactate-accumulation-and-leads-to-nk-cell-dysfunction-in-pancreatic-cancer
#59
JOURNAL ARTICLE
Wanli Ge, Lingdong Meng, Shouji Cao, Chaoqun Hou, Xiaole Zhu, Dongya Huang, Qiang Li, Yunpeng Peng, Kuirong Jiang
BACKGROUND: Pancreatic cancer (PC) is a malignant cancer with poor prognosis and high mortality rate. Sine oculis homeobox homolog 1 (SIX1) participates in the development of many cancers. However, the function of SIX1 in PC is not fully understood. METHODS: SIX1 expression was determined using immunohistochemistry in PC tissues and cell lines. Glucose consumption, lactate production, and ATP assays were used to detect the function of SIX1. PC cells and NK cells were cocultured to study the effect of SIX1 overexpression in PC cells on NK cell function...
2023: Journal of Immunology Research
https://read.qxmd.com/read/36895027/gpr116-receptor-regulates-the-antitumor-function-of-nk-cells-via-g%C3%AE-q-hif1%C3%AE-nf-%C3%AE%C2%BAb-signaling-pathway-as-a-potential-immune-checkpoint
#60
JOURNAL ARTICLE
Dandan Guo, Chenxu Jin, Yaoxin Gao, Haizhen Lin, Li Zhang, Ying Zhou, Jie Yao, Yixin Duan, Yaojun Ren, Xinhui Hui, Yujia Ge, Renzheng Yang, Wenzheng Jiang
BACKGROUND: NK cell is one of innate immune cells and can protect the body from cancer-initiating cells. It has been reported that GPR116 receptor is involved in inflammation and tumors. However, the effect of GPR116 receptor on the NK cells remains largely unclear. RESULTS: We discovered that GPR116-/- mice could efficiently eliminate pancreatic cancer through enhancing the proportion and function of NK cells in tumor. Moreover, the expression of GPR116 receptor was decreased upon the activation of the NK cells...
March 9, 2023: Cell & Bioscience
keyword
keyword
57749
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.